In summary, our investigations revealed that exogenously expressed ADAMTS16 missense mutations lead to cellular changes that enhance cisplatin sensitivity or inhibit cell growth and suppress tumor invasion and migration in platinum-resistant ovarian cancer. Here, ADAMTS16 is linked to ovarian cancer.